Clinical Trials Directory

Trials / Completed

CompletedNCT01656915

Ex Vivo LPS Stimulation in Healthy and Compromised Subjects

Status
Completed
Phase
Study type
Observational
Enrollment
36 (actual)
Sponsor
TNO · Academic / Other
Sex
Male
Age
35 Years – 45 Years
Healthy volunteers
Accepted

Summary

Ex vivo LPS stimulation of whole blood will be a good alternative challenge to induce an inflammatory response and examine differences in the inflammatory response between healthy and compromised subjects. The purpose of the current study is to examine the inflammatory response in a younger population (35-45 yrs old) to see whether in this population also differences in the ex vivo LPS induced cytokine response exists between healthy and compromised subjects, as is seen in elderly subjects. Overweight subjects showing a state of disturbed blood glucose control will be included as subjects with compromised health and compared to healthy lean subjects with the same age (shifting from healthy towards unhealthy, not diseased). Hypothesis Ex vivo LPS stimulation of whole blood will induce a measurable inflammatory cytokine response in a healthy population that is different from a response of the compromised population. The investigators will include subjects aged 35-45 years that differ in health characteristics, especially blood HbA1c, fat% and waist circumference.

Conditions

Timeline

Start date
2012-06-01
Primary completion
2012-08-01
Completion
2012-10-01
First posted
2012-08-03
Last updated
2013-06-19

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT01656915. Inclusion in this directory is not an endorsement.